Global infectious disease test device market size to growing at 5.6% CAGR over 2020-2027
According to the research report titled ‘Global infectious disease test device market Size study with COVID impact, by Product & Service (Assays, Kits, & Reagents, Instruments, Services and Software) by Disease Type (Hepatitis, HIV, CT/NG, HAIs, HPV, TB, Influenza, Other Diseases) by Technology (Immunodiagnostics, Clinical, Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays, Other Technologies) by End User (Hospitals/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users) and Regional Forecasts 2020-2027‘, available with Market Study Report LLC, global infectious disease test device market was valued at USD 16.4 billion in 2019 and is expected to grow with a CAGR of 5.60% during 2020-2027.
Increasing prevalence of infectious diseases such as HPV, HIV, influenza, hepatitis, and tuberculosis despite notable improvements in sanitation practices is the major factor expected to drive global infectious disease test device market growth during the forecast period.
Notably, almost all the presently available standard diagnostic test kits are used for sexually transmitted diseases and bacterial infections. Some of the tests do not have their own HCPCS codes, and instead are charged with the help of unlisted codes, which is a factor expected to restrain the market growth during forecast period. Despite that, increasing consumer awareness regarding the benefits of personalized medicine is creating opportunities for molecular diagnostics and proteomics & genomics technologies, in turn augmenting global infectious disease test device market outlook.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2706213/
Based on end user scope, global infectious disease test device industry is segmented into physician offices, hospitals/clinical laboratories, reference laboratories, academic/research institutes, and others. With regards to technology spectrum, the industry is bifurcated into DNA microarrays, INAAT, immunodiagnostics, PCR, clinical microbiology, DNA sequencing & NGS, and others.
As per disease type, the industry is segmented into CT/NG, Hepatitis, TB, Influenza, HPV, HAIs, HIV, and others. Speaking of the product & service terrain, global infectious disease test device market is bifurcated into services & software, assays, kits, & reagents, and instruments.
From regional frame of reference, North America accounted for 44% share of worldwide infectious disease test device market in 2019 and is expected to showcase modest growth trends during the forecast period, mainly due to rise in awareness among practitioners and patients, favorable government measures, and presence of robust healthcare infrastructure in the region.
Meanwhile, Asia Pacific infectious disease test device industry is expected to witness the highest growth rate through 2027, owing to favorable government measures for testing of infectious disease. Further, unmet medical needs, economic development, and significant rise in disposable income, along with surging healthcare expenditure in emerging nations such as China, India, and South Korea are swaying the business dynamics in Asia Pacific.
Major players influencing global infectious disease test device market trends include Bio-Rad Laboratories, Becton, Dickinson & Company, Luminex Corporation, Abbott Laboratories, BioMerieux SA, DiaSorin Inc., Siemens AG, Roche Diagnostics AG, Quidel Corporation, Danaher Corporation, Meridian Bioscience Inc., and Thermo Fisher Scientific Inc.
To access a sample pages of this report titled “Global infectious disease test device market Size study with COVID impact, by Product & Service (Assays, Kits, & Reagents, Instruments, Services and Software) by Disease Type (Hepatitis, HIV, CT/NG, HAIs, HPV, TB, Influenza, Other Diseases) by Technology (Immunodiagnostics, Clinical, Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays, Other Technologies) by End User (Hospitals/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users) and Regional Forecasts 2020-2027” in detail along with the table of contents, please click the link below:
Global Immunoprotein Diagnostic Testing Market Size study, Regional Forecasts 2020-2027
Global Immunoprotein Diagnostic Testing Market is valued approximately at USD 10.1 billion in 2019 and is anticipated to grow with a growth rate of more than 6.6% over the forecast period 2020-2027. Immunoprotein diagnostic testing detects the level of immunoproteins in the body such as, pre-albumin, immunoglobulin, among others. With the growing incidences & prevalence of infectious and chronic diseases such as diabetes, heart disease, arthritis, kidney disease etc., rise in geriatric population, and growth in demand for early diagnostic services is likely to propel the immunoprotein diagnostic testing market.
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.
Market Study Report LLC
Toll Free: 1-866-764-2150